HB 1223
  • Introduced
    Mar 31, 2026
  • Passed House
    May 11, 2026
  • Passed Senate
    May 26, 2026
  • Became Law
HB 1223
Louisiana House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
ECONOMIC DEVELOPMENT: Establishes the Louisiana Clinical Trial Competitiveness and Patient Access Act
Last Action See all actions
House • Jun 02, 2026: Sent to the Governor for executive approval.
Latest Bill Text See all bill texts
HB1223 Enrolled

Summary

Comments on HB 1223

Tweets

Whip Lists

Sponsors
Votes
May 11, 2026, House
FINAL PASSAGE (#1141)
YES: 94
NO: 0
OTHER: 11
YES: 94

NO: 0

    ABSENT: 11

    Sources
    May 26, 2026, Senate
    FINAL PASSAGE (#1354)
    YES: 38
    NO: 0
    OTHER: 1
    YES: 38

    NO: 0

      ABSENT: 1

      Sources
      May 29, 2026, House
      CONCUR IN SENATE AMENDMENTS (#1713)
      YES: 98
      NO: 0
      OTHER: 7
      YES: 98

      NO: 0

        ABSENT: 7

        Sources
        Actions
        • Jun 02, 2026 | House
          • Sent to the Governor for executive approval.
        • Jun 01, 2026 | Senate
          • Signed by the President of the Senate.
        • May 31, 2026 | House
          • Enrolled and signed by the Speaker of the House.
        • May 29, 2026 | House
          • Read by title, roll called, yeas 98, nays 0, Senate amendments concurred in.
        • May 27, 2026 | House
          • Scheduled for concurrence on 05/29/2026.
        • May 26, 2026 | House
          • Received from the Senate with amendments.
        • May 26, 2026 | Senate
          • Rules suspended. The amended bill was read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
        • May 25, 2026 | Senate
          • Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
        • May 21, 2026 | Senate
          • Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
        • May 20, 2026 | Senate
          • Reported with amendments.
        • May 13, 2026 | Senate
          • Read second time by title and referred to the Committee on Commerce, Consumer Protection and International Affairs.
        • May 12, 2026 | Senate
          • Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
        • May 11, 2026 | House
          • Called from the calendar.
          • Read third time by title, amended, roll called on final passage, yeas 94, nays 0. Finally passed, title adopted, ordered to the Senate.
        • May 07, 2026 | House
          • Called from the calendar.
          • Read by title, returned to the calendar.
          • Notice given.
          • Scheduled for floor debate on 05/11/2026.
        • May 05, 2026 | House
          • Called from the calendar.
          • Read by title, returned to the calendar.
          • Notice given.
          • Scheduled for floor debate on 05/07/2026.
        • Apr 27, 2026 | House
          • Read by title, returned to the calendar.
          • Notice given.
          • Scheduled for floor debate on 05/05/2026.
        • Apr 23, 2026 | House
          • Scheduled for floor debate on 04/27/2026.
        • Apr 22, 2026 | House
          • Read by title, amended, ordered engrossed, passed to 3rd reading.
        • Apr 21, 2026 | House
          • Reported with amendments (12-0).
        • Apr 01, 2026 | House
          • Read by title, under the rules, referred to the Committee on Commerce.
        • Mar 31, 2026 | House
          • Read by title. Lies over under the rules.
        Bill Texts
        Documents
        Sources